NZ600243A - Combination of theobromine with a decongestant and its use for the treatment of cough - Google Patents

Combination of theobromine with a decongestant and its use for the treatment of cough

Info

Publication number
NZ600243A
NZ600243A NZ600243A NZ60024310A NZ600243A NZ 600243 A NZ600243 A NZ 600243A NZ 600243 A NZ600243 A NZ 600243A NZ 60024310 A NZ60024310 A NZ 60024310A NZ 600243 A NZ600243 A NZ 600243A
Authority
NZ
New Zealand
Prior art keywords
decongestant
theobromine
cough
treatment
combination
Prior art date
Application number
NZ600243A
Other languages
English (en)
Inventor
John Brew
Robin Mark Bannister
Original Assignee
Biocopea Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biocopea Ltd filed Critical Biocopea Ltd
Publication of NZ600243A publication Critical patent/NZ600243A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Pulmonology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NZ600243A 2009-12-14 2010-12-14 Combination of theobromine with a decongestant and its use for the treatment of cough NZ600243A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0921805.8A GB0921805D0 (en) 2009-12-14 2009-12-14 Drug composition and its use in therapy
PCT/GB2010/052085 WO2011073646A1 (en) 2009-12-14 2010-12-14 Combination of theobromine with a decongestant and its use for the treatment of cough

Publications (1)

Publication Number Publication Date
NZ600243A true NZ600243A (en) 2013-07-26

Family

ID=41667045

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ600243A NZ600243A (en) 2009-12-14 2010-12-14 Combination of theobromine with a decongestant and its use for the treatment of cough

Country Status (18)

Country Link
EP (1) EP2512464A1 (ja)
JP (2) JP2013513651A (ja)
CN (2) CN105816462A (ja)
AU (1) AU2010332494B2 (ja)
BR (1) BR112012014161A2 (ja)
CA (1) CA2784214C (ja)
CO (1) CO6541630A2 (ja)
EC (1) ECSP12012132A (ja)
GB (1) GB0921805D0 (ja)
IL (1) IL220383A (ja)
MX (1) MX343222B (ja)
NZ (1) NZ600243A (ja)
PE (1) PE20121537A1 (ja)
RU (1) RU2564904C2 (ja)
SG (2) SG10201408377QA (ja)
UA (1) UA105944C2 (ja)
WO (1) WO2011073646A1 (ja)
ZA (1) ZA201204293B (ja)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10016437B2 (en) 2009-06-16 2018-07-10 Infirst Healthcare Limited Drug combinations and uses in treating a coughing condition
US9308211B2 (en) 2009-06-16 2016-04-12 Infirst Healthcare Limited Drug combinations and uses in treating a coughing condition
GB201111485D0 (en) * 2011-07-05 2011-08-17 Biocopea Ltd Drug composition and its use in therapy
GB0910375D0 (en) 2009-06-16 2009-07-29 Biocopea Ltd Drug composition and its use in therapy
US9314465B2 (en) 2009-06-16 2016-04-19 Infirst Healthcare Limited Drug combinations and uses in treating a coughing condition

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7604094A (en) * 1993-09-07 1995-03-27 Procter & Gamble Company, The Compositions containing an amino acid salt of propionic acid non-steroidal anti-inflammatory agent and at least one of a decongestant, an expectorant, an antihistamine and an antitussive
HUP9700654A2 (hu) * 1997-03-26 1999-09-28 Dezső Korbonits Teobromin tartalmú köhögéscsillapító készítmények
US6417206B1 (en) * 2001-01-26 2002-07-09 Medpointe Healthcare Inc. Antitussive/antihist aminic/decongestant compositions
JP2002308761A (ja) * 2001-04-09 2002-10-23 Taisho Pharmaceut Co Ltd 風邪用咳止め薬
JP2003128549A (ja) * 2001-08-15 2003-05-08 Rohto Pharmaceut Co Ltd 粘膜適用組成物
JP4377564B2 (ja) * 2002-05-02 2009-12-02 ロート製薬株式会社 内服用組成物
RU2311919C2 (ru) * 2002-12-30 2007-12-10 Каунсел Оф Сайнтифик Энд Индастриал Рисерч Разработка противокашлевой и смягчающей горло травяной композиции
US20040202677A1 (en) * 2003-04-10 2004-10-14 Hopkins Kevin J. Method of enhanced regional body fat reduction
US20060153926A1 (en) * 2005-01-10 2006-07-13 Bascom Charles C Compositions, products and methods for controlling weight in a mammal
US20080003280A1 (en) * 2006-06-26 2008-01-03 Levine Brian M Combination cough treatment compounds and method of treating common coughs
KR20080009994A (ko) * 2006-07-25 2008-01-30 안국약품 주식회사 기침 치료용 조성물
CN100518775C (zh) * 2007-03-16 2009-07-29 邓丽菊 一种治疗咳喘的药物组合物及其制剂

Also Published As

Publication number Publication date
UA105944C2 (uk) 2014-07-10
CN105816462A (zh) 2016-08-03
WO2011073646A1 (en) 2011-06-23
RU2564904C2 (ru) 2015-10-10
EP2512464A1 (en) 2012-10-24
BR112012014161A2 (pt) 2016-05-17
RU2012129839A (ru) 2014-01-27
JP2013513651A (ja) 2013-04-22
CN102740843A (zh) 2012-10-17
PE20121537A1 (es) 2012-12-21
MX2012006625A (es) 2012-10-05
AU2010332494B2 (en) 2015-01-15
CO6541630A2 (es) 2012-10-16
IL220383A (en) 2017-01-31
SG10201408377QA (en) 2015-02-27
CA2784214C (en) 2018-01-09
MX343222B (es) 2016-10-28
ZA201204293B (en) 2013-02-27
CA2784214A1 (en) 2011-06-23
IL220383A0 (en) 2012-08-30
AU2010332494A1 (en) 2012-06-14
ECSP12012132A (es) 2012-09-28
JP2016040279A (ja) 2016-03-24
SG181686A1 (en) 2012-07-30
GB0921805D0 (en) 2010-01-27

Similar Documents

Publication Publication Date Title
WO2009152189A8 (en) Low dose topiramate/phentermine compostion and methods of use thereof
WO2008131056A3 (en) Sustained release monoeximic formulations of opioid and nonopioid analgesics
AR124500A2 (es) Aumento de la biodisponibilidad de droga en terapia naltrexona
NZ605888A (en) Pharmaceutical dosage form comprising 6’-fluoro-(n-methyl- or n,n-dimethyl-)-4-phenyl-4’,9’-dihydro-3’h-spiro[cyclohexane-1,1’-pyrano[3,4,b]indol]-4-amine for the treatment of nociceptive pain
NZ713202A (en) Diagnosis and treatments relating to th2 inhibition
WO2008131057A3 (en) Sustained release formulations of opioid and nonopioid analgesics
MX2010005631A (es) Nuevos compuestos de hidrocarburo ciclicos para el tratamiento de enfermedades.
NZ589445A (en) Rasagiline for parkinson's disease modification
RS51688B (en) METHOTREXATE CONCENTRATED SOLUTIONS
AR065392A1 (es) Metodos para el tratamiento por inhalacion de una enfermedad o estado respiratorio
WO2012007159A3 (en) Novel gastro-retentive dosage forms
AR124497A2 (es) Métodos para tratar los atracones o la ingesta compulsiva de alimentos; uso de buproprion y naltrexona para preparar un medicamento para dichos métodos, y composición farmacéutica
ITBO20110012A1 (it) Composizioni farmaceutiche comprendenti rifaximina e loro uso.
NZ600243A (en) Combination of theobromine with a decongestant and its use for the treatment of cough
NZ595767A (en) Composition for the treatment of prostate cancer
BR112012016783A2 (pt) "usos do composto de naltrexona ou sal farmaceuticamente aceitável da mesma a bupropiona ou sal farmaceuticamente aceitável da mesma ou de composição dos mesmos e métodos para proporcionar terapia"
NZ594067A (en) VISFATIN THERAPEUTIC AGENTS (PEPTIDES, siRNA, FK-866, APO866 ) FOR THE TREATMENT OF ACNE AND OTHER CONDITIONS
WO2011047837A3 (de) Schmelzgranuliertes cinacalcet
AR079000A1 (es) Terapia anticancerosa dirigida a celulas madre cancerosas resistentes a las drogas
MX341660B (es) Agonista del receptor de ghrelina para el tratamiento de caquexia.
WO2009019693A3 (en) Analgesic effect of jasmonate derivatives
NZ604009A (en) A combination composition comprising ibuprofen and paracetamol
MX2008015323A (es) Composicion farmaceutica que comprende ciclobenzaprina y aceclofenac en asociacion.
MD3422G2 (ro) Procedeu de profilaxie şi tratament al knemidocoptozei galinaceelor
GR1008614B (el) 3,3-διαφαινυλ-ν-(φαινυλαιθυλ)προπαν-1-αμινη: ως νεος και επιλεκτικος προσδετης των σιγμα-1 υποδοχεων, με αντι-απο πτωτικες (κυτταρο-προστατευτικες) ιδιοτητες και με πρωτοτυπη αντικαρκινικη δραση

Legal Events

Date Code Title Description
PSEA Patent sealed
RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 14 DEC 2015 BY OLCOTT

Effective date: 20141012

ASS Change of ownership

Owner name: INFIRST HEALTHCARE LIMITED, GB

Effective date: 20141106

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 14 DEC 2016 BY OLCOTT

Effective date: 20151128

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 14 DEC 2017 BY OLCOTT INTERANTIONAL

Effective date: 20161205

LAPS Patent lapsed